C. David Nicholson, - Net Worth and Insider Trading

C. David Nicholson, Net Worth

The estimated net worth of C. David Nicholson, is at least $4,100 dollars as of 2024-05-23. C. David Nicholson, is the Director of Actinium Pharmaceuticals Inc and owns about 500 shares of Actinium Pharmaceuticals Inc (ATNM) stock worth over $4,100. Details can be seen in C. David Nicholson,'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that C. David Nicholson, has not made any transactions after 2016-04-14 and currently still holds the listed stock(s).

Transaction Summary of C. David Nicholson,

To

C. David Nicholson, Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, C. David Nicholson, owns 2 companies in total, including Actinium Pharmaceuticals Inc (ATNM) , and Adverum Biotechnologies Inc (ADVM) .

Click here to see the complete history of C. David Nicholson,’s form 4 insider trades.

Insider Ownership Summary of C. David Nicholson,

Ticker Comapny Transaction Date Type of Owner
ATNM Actinium Pharmaceuticals Inc 2016-04-14 director
ADVM Adverum Biotechnologies Inc 2023-11-03 director

C. David Nicholson, Latest Holdings Summary

C. David Nicholson, currently owns a total of 1 stock. C. David Nicholson, owns 500 shares of Actinium Pharmaceuticals Inc (ATNM) as of April 14, 2016, with a value of $4,100.

Latest Holdings of C. David Nicholson,

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ATNM Actinium Pharmaceuticals Inc 2016-04-14 500 8.20 4,100

Holding Weightings of C. David Nicholson,


C. David Nicholson, Form 4 Trading Tracker

According to the SEC Form 4 filings, C. David Nicholson, has made a total of 0 transactions in Actinium Pharmaceuticals Inc (ATNM) over the past 5 years. The most-recent trade in Actinium Pharmaceuticals Inc is the acquisition of 167 shares on April 14, 2016, which cost C. David Nicholson, around $10,000.

Insider Trading History of C. David Nicholson,

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

C. David Nicholson, Trading Performance

GuruFocus tracks the stock performance after each of C. David Nicholson,'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by C. David Nicholson, is -15.42%. GuruFocus also compares C. David Nicholson,'s trading performance to market benchmark return within the same time period. The performance of stocks bought by C. David Nicholson, within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how C. David Nicholson,'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of C. David Nicholson,

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -10.95
Relative Return to S&P 500(%) -9.21

C. David Nicholson, Ownership Network

Ownership Network List of C. David Nicholson,

No Data

Ownership Network Relation of C. David Nicholson,


C. David Nicholson, Owned Company Details

What does Actinium Pharmaceuticals Inc do?

Who are the key executives at Actinium Pharmaceuticals Inc?

C. David Nicholson, is the director of Actinium Pharmaceuticals Inc. Other key executives at Actinium Pharmaceuticals Inc include VP & Finance and Corporate Dev. Steve O'loughlin , Chief Scientific Officer Dale L. Ludwig , and Chief Commercial Officer Anil Kapur .

Actinium Pharmaceuticals Inc (ATNM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Actinium Pharmaceuticals Inc (ATNM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Actinium Pharmaceuticals Inc (ATNM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Actinium Pharmaceuticals Inc (ATNM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Actinium Pharmaceuticals Inc Insider Transactions

No Available Data

C. David Nicholson, Mailing Address

Above is the net worth, insider trading, and ownership report for C. David Nicholson,. You might contact C. David Nicholson, via mailing address: 103 Childs Road, Baskin Ridge Nj 07092.

Discussions on C. David Nicholson,

No discussions yet.